Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-? for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis

These results suggest that combined therapy consisting of intraarterial cisplatin infusion and systemic IFN-alpha may be useful as a palliative treatment for HCC patients with major vascular involvement or extrahepatic metastasis.